目次

Table of contents

1. Executive Summary

2. Introduction
2.1 Healthcare Contract Manufacturing Organization (CMO): An Overview
2.1.1 Benefits Of Healthcare CMOs
2.2 Healthcare CMO Segmentation: An Overview
2.2.1 Healthcare CMO Segmentation

3. Global Market Analysis
3.1 Global Healthcare Contract Manufacturing Organization (CMO) Market: An Analysis
3.1.1 Global Healthcare CMO Market: An Overview
3.1.2 Global Healthcare Contract Manufacturing Organization (CMO) Market by Value
3.1.3 Global Healthcare Contract Manufacturing Organization (CMO) Market by Type (Pharmaceutical and Medical Device)
3.1.4 Global Healthcare Contract Manufacturing Organization (CMO) Market by Region (North America, Europe, Asia Pacific, and rest of the World (ROW)
3.2 Global Healthcare CMO Market: Type Analysis
3.2.1 Global Healthcare CMO Market by Type: An Overview
3.2.2 Global Pharmaceutical CMO Market by Value
3.2.3 Global Pharmaceutical CMO Market by Service (Active Pharmaceutical Ingredients (API) and Others)
3.2.3 Global Pharmaceutical CMO Market by Service: An Overview
3.2.4 Global Active Pharmaceutical Ingredients (API) CMO Market by Value
3.2.5 Global Other Pharmaceuticals CMO Market by Value
3.2.6 Global Medical Devices CMO Market by Value

4. Regional Market Analysis
4.1 North America Healthcare CMO Market: An Analysis
4.1.1 North America Healthcare CMO Market: An Overview
4.1.2 North America Healthcare CMO Market by Value
4.1.3 North America Healthcare CMO Market by Region (The US, Canada and Mexico)
4.1.4 The US Healthcare CMO Market by Value
4.1.5 The US Healthcare CMO Market by Type (Pharmaceutical and Medical Device)
4.1.6 The US Pharmaceutical Healthcare CMO Market by Value
4.1.7 The US Medical Devices Healthcare CMO Market by Value
4.1.8 Canada Healthcare CMO Market by Value
4.1.9 Mexico Healthcare CMO Market by Value
4.2 Europe Healthcare CMO Market: An Analysis
4.2.1 Europe Healthcare CMO Market: An Overview
4.2.2 Europe Healthcare CMO Market by Value
4.2.3 Europe Healthcare CMO Market by Region (Germany, The UK, France, Italy, Spain, and Rest of the Europe)
4.2.4 Germany Healthcare CMO Market by Value
4.2.5 The UK Healthcare CMO Market by Value
4.2.6 France Healthcare CMO Market by Value
4.2.7 Italy Healthcare CMO Market by Value
4.2.8 Spain Healthcare CMO Market by Value
4.2.9 Rest of Europe Healthcare CMO Market by Value
4.3 Asia Pacific Healthcare CMO Market: An Analysis
4.3.1 Asia Pacific Healthcare CMO Market: An Overview
4.3.2 Asia Pacific Healthcare CMO Market by Value
4.3.3 Asia Pacific Healthcare CMO Market by Region (China, Japan, India, South Korea, and Rest of the Asia Pacific)
4.3.4 China Healthcare CMO Market by Value
4.3.5 Japan Healthcare CMO Market by Value
4.3.6 India Healthcare CMO Market by Value
4.3.7 South Korea Healthcare CMO Market by Value
4.3.8 Rest of Asia Pacific Healthcare CMO Market by Value
4.4 Rest of World Healthcare CMO Market: An Analysis
4.4.1 Rest of World Healthcare CMO Market: An Overview
4.4.2 Rest of World Healthcare CMO Market by Value

5. Impact of Covid-19
5.1 Surge in Contracts to CDMOs
5.2 Supply Chain Issues Amidst Surge in Demand for CDMOs
5.3 Preparedness Measures in the Event of Supply Chain Disruption
5.4 Post-COVID Scenario

6. Market Dynamics
6.1 Growth Drivers
6.1.1 Surging Geriatric Population
6.1.2 Rising Healthcare Expenditure
6.1.3 Increasing Spread of Chronic Diseases
6.1.4 Escalating Demand for Generic Drugs
6.1.5 Growing Inclination Towards Herbal Products
6.1.6 Increasing Demand for Active Pharmaceutical Ingredient (API)
6.2 Challenges
6.2.1 Rapid Technological Advancements
6.2.2 Dependent on Patents, Copyrights, Trademarks and Trade Secrets
6.3 Market Trends
6.3.1 Escalating Role of Artificial Intelligence Technology
6.3.2 Evolution of Advanced Respiratory Equipment

7. Competitive Landscape
7.1 Global Healthcare CMO Market Players Financial Comparison
7.2 Global Healthcare CMO Market Players by Research & Development (R&D) Expenses

8. Company Profiles
8.1 Catalent Pharma Solutions Inc.
8.1.1 Business Overview
8.1.2 Operating Segments
8.1.3 Business Strategy
8.2 Samsung Biologics Co. Ltd.
8.2.1 Business Overview
8.2.2 Operating Segments
8.2.3 Business Strategy
8.3 Aurobindo Pharma Limited
8.3.1 Business Overview
8.3.2 Operating Segments
8.3.3 Business Strategy
8.4 Boehringher Ingelheim
8.4.1 Business Overview
8.4.2 Operating Segments
8.4.3 Business Strategy
8.5 Integer Holdings Corporation
8.5.1 Business Overview
8.5.2 Operating Segments
8.5.3 Business Strategy
8.6 Piramal Enterprises Limited
8.6.1 Business Overview
8.6.2 Operating Segments
8.6.3 Business Strategy
8.7 Lonza Group AG
8.7.1 Business Overview
8.7.2 Operating Segments
8.7.3 Business Strategy
8.8 Koninklijke DSM N.V. (Royal DSM)
8.8.1 Business Overview
8.8.2 Operating Segments
8.8.3 Business Strategy
8.9 Thermo Fisher Scientific Inc.
8.9.1 Business Overview
8.9.2 Operating Segments
8.9.3 Business Strategy
8.10 Recipharm AB
8.10.1 Business Overview
8.10.2 Business Strategy
8.11 Fareva Group
8.11.1 Business Overview
8.11.2 Business Strategy
8.12 Symbiosis Pharmaceutical Services
8.12.1 Business Overview
8.12.2 Business Strategy

Table Of Figures
Figure 1: Benefits Of Healthcare CMOs
Figure 2: Healthcare CMO Segmentation
Figure 3: Global Healthcare CMO Market by Value; 2017-2021 (US$ Billion)
Figure 4: Global Healthcare CMO Market by Value; 2022-2027 (US$ Billion)
Figure 5: Global Healthcare CMO Market by Type; 2021 (Percentage, %)
Figure 6: Global Healthcare CMO Market by Region; 2021 (Percentage, %)
Figure 7: Global Pharmaceutical CMO Market by Value; 2017-2021 (US$ Billion)
Figure 8: Global Pharmaceutical CMO Market by Value; 2022-2027 (US$ Billion)
Figure 9: Global Pharmaceutical CMO Market by Service; 2021 (Percentage, %)
Figure 10: Global Active Pharmaceutical Ingredients (API) CMO Market by Value; 2017-2021 (US$ Billion)
Figure 11: Global Active Pharmaceutical Ingredients (API) CMO Market by Value; 2022-2027 (US$ Billion)
Figure 12: Global Other Pharmaceuticals CMO Market by Value; 2017-2021 (US$ Billion)
Figure 13: Global Other Pharmaceuticals CMO Market by Value; 2022-2027 (US$ Billion)
Figure 14: Global Medical Devices CMO Market by Value; 2017-2021 (US$ Billion)
Figure 15: Global Medical Devices CMO Market by Value; 2022-2027 (US$ Billion)
Figure 16: North America Healthcare CMO Market by Value; 2017-2021 (US$ Billion)
Figure 17: North America Healthcare CMO Market by Value; 2022-2027 (US$ Billion)
Figure 18: North America Healthcare CMO Market by Region; 2021 (Percentage, %)
Figure 19: The US Healthcare CMO Market by Value; 2017-2021 (US$ Billion)
Figure 20: The US Healthcare CMO Market by Value; 2022-2027 (US$ Billion)
Figure 21: The US Healthcare CMO Market by Type; 2021 (Percentage, %)
Figure 22: The US Pharmaceutical Healthcare CMO Market by Value; 2017-2021 (US$ Billion)
Figure 23: The US Pharmaceutical Healthcare CMO Market by Value; 2022-2027 (US$ Billion)
Figure 24: The US Medical Devices Healthcare CMO Market by Value; 2017-2021 (US$ Billion)
Figure 25: The US Medical Devices Healthcare CMO Market by Value; 2022-2027 (US$ Billion)
Figure 26: Canada Healthcare CMO Market by Value; 2017-2021 (US$ Billion)
Figure 27: Canada Healthcare CMO Market by Value; 2022-2027 (US$ Billion)
Figure 28: Mexico Healthcare CMO Market by Value; 2017-2021 (US$ Billion)
Figure 29: Mexico Healthcare CMO Market by Value; 2022-2027 (US$ Billion)
Figure 30: Europe Healthcare CMO Market by Value; 2017-2021 (US$ Billion)
Figure 31: Europe Healthcare CMO Market by Value; 2022-2027 (US$ Billion)
Figure 32: Europe Healthcare CMO Market by Region; 2021 (Percentage, %)
Figure 33: Germany Healthcare CMO Market by Value; 2017-2021 (US$ Billion)
Figure 34: Germany Healthcare CMO Market by Value; 2022-2027 (US$ Billion)
Figure 35: The UK Healthcare CMO Market by Value; 2017-2021 (US$ Billion)
Figure 36: The UK Healthcare CMO Market by Value; 2022-2027 (US$ Billion)
Figure 37: France Healthcare CMO Market by Value; 2017-2021 (US$ Billion)
Figure 38: France Healthcare CMO Market by Value; 2022-2027 (US$ Billion)
Figure 39: Italy Healthcare CMO Market by Value; 2017-2021 (US$ Billion)
Figure 40: Italy Healthcare CMO Market by Value; 2022-2027 (US$ Billion)
Figure 41: Spain Healthcare CMO Market by Value; 2017-2021 (US$ Billion)
Figure 42: Spain Healthcare CMO Market by Value; 2022-2027 (US$ Billion)
Figure 43: Rest of Europe Healthcare CMO Market by Value; 2017-2021 (US$ Billion)
Figure 44: Rest of Europe Healthcare CMO Market by Value; 2022-2027 (US$ Billion)
Figure 45: Asia Pacific Healthcare CMO Market by Value; 2017-2021 (US$ Billion)
Figure 46: Asia Pacific Healthcare CMO Market by Value; 2022-2027 (US$ Billion)
Figure 47: Asia Pacific Healthcare CMO Market by Region; 2021 (Percentage, %)
Figure 48: China Healthcare CMO Market by Value; 2017-2021 (US$ Billion)
Figure 49: China Healthcare CMO Market by Value; 2022-2027 (US$ Billion)
Figure 50: Japan Healthcare CMO Market by Value; 2017-2021 (US$ Billion)
Figure 51: Japan Healthcare CMO Market by Value; 2022-2027 (US$ Billion)
Figure 52: India Healthcare CMO Market by Value; 2017-2021 (US$ Billion)
Figure 53: India Healthcare CMO Market by Value; 2022-2027 (US$ Billion)
Figure 54: South Korea Healthcare CMO Market by Value; 2017-2021 (US$ Billion)
Figure 55: South Korea Healthcare CMO Market by Value; 2022-2027 (US$ Billion)
Figure 56: Rest of Asia Pacific Healthcare CMO Market by Value; 2017-2021 (US$ Billion)
Figure 57: Rest of Asia Pacific Healthcare CMO Market by Value; 2022-2027 (US$ Billion)
Figure 58: Rest of World Healthcare CMO Market by Value; 2017-2021 (US$ Billion)
Figure 59: Rest of World Healthcare CMO Market by Value; 2022-2027 (US$ Billion)
Figure 60: Global Population Proportion Above 65 Years of Age; 2019 & 2030 (Million)
Figure 61: Global Healthcare Expenditure; 2017 & 2022 (US$ Trillion)
Figure 62: Global Chronic Disease Growth; 2016-2025 (Percentage, %)
Figure 63: Global Generic Drugs Market Value, 2020-2025 (US$ Billion)
Figure 64: Global Natural And Organic Cosmetics And Personal Care Market Value, 2021-2027 (US$ Billion)
Figure 65: Global Healthcare Artificial Intelligence Market Value; 2020-2025 (US$ Billion)
Figure 66: The Global Healthcare CMO Market Players by Research & Development (R&D) Expenses; 2020 & 2021 (US$ Million)
Figure 67: Catalent, Inc. Net Revenue by Segments; 2021 (Percentage, %)
Figure 68: Samsung Biologics Co. Ltd. Revenue by Product Type; 2021 (Percentage, %)
Figure 69: Aurobindo Pharma Limited Revenue by Business Segments; 2021 (Percentage, %)
Figure 70: Boehringher Ingelheim Net Sales by Segments; 2021 (Percentage, %)
Figure 71: Integer Holdings Corporation Net Sales by Segments; 2021 (Percentage, %)
Figure 72: Piramal Enterprises Limited Net Sales by Business; 2021 (Percentage, %)
Figure 73: Lonza Group AG Sales by Segments; 2021 (Percentage, %)
Figure 74: Koninklijke DSM N.V. Net Sales by Business Segments; 2021 (Percentage, %)
Figure 75: Thermo Fisher Scientific Inc. Revenues by Segments; 2021 (Percentage, %)
Table 1: Contracts Placed with Pharmaceutical CDMOs; 2020
Table 2: Global Healthcare CMO Market Players Financial Comparison; 2021